Literature DB >> 12164260

Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis.

M Markowska1, R Oberle, S Juzwin, C P Hsu, M Gryszkiewicz, A J Streeter.   

Abstract

INTRODUCTION: The aim of this investigation was to evaluate methods for increasing Caco-2 cell throughput for assessing drug intestinal absorption. The use of 6-, 12-, and 24-well membranes and the effect of membrane size on permeability and the integrity of the Caco-2 cell monolayer were assessed. In an effort to optimize the assessment of drug permeability, increased throughput was investigated by testing compounds singly or as mixtures of analytes.
METHOD: The transepithelial electrical resistance (TEER) of cell monolayers was measured on 0.33, 1.0, and 4.7 cm2 polycarbonate membranes using EVOM, over a 25-day period. Absorptive transport was determined on all compounds tested using LC-MS/MS assays, or liquid scintillation spectrometry.
RESULTS: The effect of multiple compounds in one well compared to single compounds was assessed with atenolol, nadolol, metoprolol, and propranolol for mixtures of four compounds and with RWJ-53308, atenolol, terbutaline, propranolol, naproxen, piroxicam, topiramate, and furosemide for mixtures of eight compounds. The apparent permeability (Papp) values correlated well between single analytes and mixtures of four and eight analytes in each well. Drug permeability decreased slightly with an increase in well size. The TEER value increased with the number of days in culture for each of the 6-, 12-, and 24-well sizes. DISCUSSION: It was demonstrated that the 24-well format system is ideal for high-throughput assessment. Furthermore, the approach of mixing four or eight analytes in each well to further increase throughput was also demonstrated to be valid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12164260     DOI: 10.1016/s1056-8719(01)00161-7

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  17 in total

1.  Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

Authors:  Jochem Alsenz; E Haenel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

2.  Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

Authors:  V Berezowski; C Landry; S Lundquist; L Dehouck; R Cecchelli; M P Dehouck; L Fenart
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

3.  Differentiation- and polarization-dependent zinc tolerance in Caco-2 cells.

Authors:  Nina Zemann; Adolf Zemann; Petra Klein; Ibrahim Elmadfa; Manfred Huettinger
Journal:  Eur J Nutr       Date:  2010-11-20       Impact factor: 5.614

Review 4.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

5.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

6.  Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers.

Authors:  Leena A Laitinen; Päivi S M Tammela; Anna Galkin; Heikki J Vuorela; Martti L A Marvola; Pia M Vuorela
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

7.  N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers.

Authors:  Leena Laitinen; Heli Kangas; Ann Marie Kaukonen; Kati Hakala; Tapio Kotiaho; Risto Kostiainen; Jouni Hirvonen
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

8.  High glucose concentration in isotonic media alters caco-2 cell permeability.

Authors:  Vanessa M D'Souza; Howard G Shertzer; Anil G Menon; Giovanni M Pauletti
Journal:  AAPS PharmSci       Date:  2003

9.  Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies.

Authors:  Lidiane M Monteiro; Viviane F Lione; Flavia A do Carmo; Lilian H do Amaral; Julianna H da Silva; Luiz E Nasciutti; Carlos R Rodrigues; Helena C Castro; Valeria P de Sousa; Lucio M Cabral
Journal:  Int J Nanomedicine       Date:  2012-09-28

10.  Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal.

Authors:  Jagat R Kanwar; Rupinder K Kanwar
Journal:  BMC Immunol       Date:  2009-01-31       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.